Jinyu Bio-Technology's subsidiary obtains new animal drug registration certificate.

16:04 26/03/2026

Biological Stock Co., Ltd. (600201.SH) announced that the fully-owned subsidiary Jin Yu You Bang Biological Technology Co., Ltd. (Jiangsu) ("Jin Yu You Bang") and other units have jointly developed a new veterinary drug called the Goose Newcastle Disease and Gosling Plague Bivalent Inactivated Vaccine (A-VII strain + GPVP3/Bac strain), which has been approved as a new veterinary drug.

Jinyu Bio-Technology (600201.SH) announced that its wholly-owned subsidiary, Jinyu Youbang Biological Technology (Jiangsu) Co., Ltd. (referred to as "Jinyu Youbang"), jointly developed with other units, the goose Newcastle disease and duck viral enteritis bivalent inactivated vaccine (A-VII + GPVP3/Bac strains) has been approved as a new veterinary drug.

Sinolink: Escalation of US-Iran conflict reverses "weak US dollar" narrative, strong assets may help reverse market decline and indicate a bottom.

Huachuang Securities: Under the impact of high oil prices in this round, the middle and upper reaches of the profit margin may have more resilience.

Hua Chuang Securities' Zhang Yu: High oil prices bring "clearing out," China's midstream market share may "rise"

Sinolink: Escalation of US-Iran conflict reverses "weak US dollar" narrative, strong assets may help reverse market decline and indicate a bottom.

Huachuang Securities: Under the impact of high oil prices in this round, the middle and upper reaches of the profit margin may have more resilience.

Hua Chuang Securities' Zhang Yu: High oil prices bring "clearing out," China's midstream market share may "rise"